All Pharma News
FDA clears Otsuka, Click`s prescription app for depression

FDA clears Otsuka, Click`s prescription app for depression
FIERCE BIOTECH
03 Apr 2024
Share Share
Otsuka and Click Thera Announce the FDA Clearance of Rejoyn for the MDD Symptoms

Otsuka and Click Thera Announce the FDA Clearance of Rejoyn for the MDD Symptoms
BUSINESSWIRE
01 Apr 2024
Share Share
Click Therapeutics and BI Announce FDA Breakthrough Device Designation for Prescription Digital Therapeutic

Click Therapeutics and BI Announce FDA Breakthrough Device Designation for Prescription Digital Therapeutic
BUSINESSWIRE
04 Jan 2024
Share Share
Click, Indivior to make digital therapeutics for addiction

Click, Indivior to make digital therapeutics for addiction
Andrea Park FIERCE BIOTECH
08 Sep 2023
Share Share
Click Therapeutics Announces Participation in Investor Events

Click Therapeutics Announces Participation in Investor Events
BUSINESSWIRE
03 Aug 2023
Share Share
Click Therapeutics & BI Pivotal Trial of Prescription Digital Therapeutics

Click Therapeutics & BI Pivotal Trial of Prescription Digital Therapeutics
BUSINESSWIRE
04 May 2023
Share Share
Boehringer Ingelheim to trial Click`s digital schizophrenia app

Boehringer Ingelheim to trial Click`s digital schizophrenia app
Conor Hale FIERCE BIOTECH
04 May 2023
Share Share
Click Therapeutics to Present at 22nd Annual Needham Healthcare Conference

Click Therapeutics to Present at 22nd Annual Needham Healthcare Conference
BUSINESSWIRE
13 Apr 2023
Share Share
Click Therapeutics Shares 2022 Accomplishments and Development Progress

Click Therapeutics Shares 2022 Accomplishments and Development Progress
BUSINESSWIRE
23 Dec 2022
Share Share
Boehringer deepens collaboration with Click Therapeutics in a deal of $460M

Boehringer deepens collaboration with Click Therapeutics in a deal of $460M
Tyler Patchen ENDPTS
19 Dec 2022
Share Share